HAWTHORNE, N.Y.--(BUSINESS WIRE)--May 20, 2022--
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the year ended March 31, 2022, after the close of market on Thursday, May 26, 2022.
The release will be accessible on Taro’s website at www.taro.com.
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220520005423/en/
William J. Coote
VP, Chief Financial Officer
Source: Taro Pharmaceutical Industries Ltd.